AAAAAA

   
Results: 1-8 |
Results: 8
AKT-1,-2, and-3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon
Authors: Zinda, MJ Johnson, MA Paul, JD Horn, C Konicek, BW Lu, ZH Sandusky, G Thomas, JE Neubauer, BL Lai, MT Graff, JR
Citation: Mj. Zinda et al., AKT-1,-2, and-3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon, CLIN CANC R, 7(8), 2001, pp. 2475-2479
Androgen antagonists: Potential role in prostate cancer prevention
Authors: Trump, DL Waldstreicher, JA Kolvenbag, G Wissel, PS Neubauer, BL
Citation: Dl. Trump et al., Androgen antagonists: Potential role in prostate cancer prevention, UROLOGY, 57(4A), 2001, pp. 64-67
Selective estrogen receptor modulators for the chemoprevention of prostatecancer
Authors: Steiner, MS Raghow, S Neubauer, BL
Citation: Ms. Steiner et al., Selective estrogen receptor modulators for the chemoprevention of prostatecancer, UROLOGY, 57(4A), 2001, pp. 68-72
Design, synthesis, and proposed active site binding analysis of monocyclic2-azetidinone inhibitors of prostate specific antigen
Authors: Adlington, RM Baldwin, JE Becker, GW Chen, BN Cheng, LF Cooper, SL Hermann, RB Howe, TJ McCoull, W McNulty, AM Neubauer, BL Pritchard, GJ
Citation: Rm. Adlington et al., Design, synthesis, and proposed active site binding analysis of monocyclic2-azetidinone inhibitors of prostate specific antigen, J MED CHEM, 44(10), 2001, pp. 1491-1508
Simple bi- and tricyclic inhibitors of human steroid 5 alpha-reductase
Authors: Abell, AD Prince, MJ McNulty, AM Neubauer, BL
Citation: Ad. Abell et al., Simple bi- and tricyclic inhibitors of human steroid 5 alpha-reductase, BIOORG MED, 10(17), 2000, pp. 1909-1911
Kinetic analysis of LY320236: competitive inhibitor of type I and non-competitive inhibitor of type II human steroid 5 alpha-reductase
Authors: McNulty, AM Audia, JE Bemis, KG Goode, RL Rocco, VP Neubauer, BL
Citation: Am. Mcnulty et al., Kinetic analysis of LY320236: competitive inhibitor of type I and non-competitive inhibitor of type II human steroid 5 alpha-reductase, J STEROID B, 72(1-2), 2000, pp. 13-21
Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27(Kip1) expression
Authors: Graff, JR Konicek, BW McNulty, AM Wang, ZJ Houck, K Allen, S Paul, JD Hbaiu, A Goode, RG Sandusky, GE Vessella, RL Neubauer, BL
Citation: Jr. Graff et al., Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27(Kip1) expression, J BIOL CHEM, 275(32), 2000, pp. 24500-24505
Growth regulation of prostatic stromal cells by prostate-specific antigen
Authors: Sutkowski, DM Goode, RL Baniel, J Teater, C Cohen, P McNulty, AM Hsiung, HM Becker, GW Neubauer, BL
Citation: Dm. Sutkowski et al., Growth regulation of prostatic stromal cells by prostate-specific antigen, J NAT CANC, 91(19), 1999, pp. 1663-1669
Risultati: 1-8 |